YD Bio

YD Bio Intangible Assets

The Intangible Assets of YD Bio (YDES) as of Oct 20, 2026 is 2.68 M USD.

Intangible Assets

2.68 MUSD

Last updated:

Intangible Assets of YD Bio is 2024 2.68 M USD. Intangible Assets of YD Bio was 2023 - USD. It decreases by % lower compared to the previous year.

The YD Bio Intangible Assets history

The YD Bio Intangible Assets history
YEARIntangible AssetsYoY
2.68 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

YD Bio Stock analysis

What does YD Bio do? YD Bio Ltd is a Taiwan-based company focused on early cancer detection tools, ophthalmologic products for dry eye conditions, and exosome-based therapeutics for complex diseases. The company generates revenue through its core areas of non-invasive cancer detection solutions, dry eye treatment products, and exosome-based therapies, targeting healthcare providers and patients seeking advanced medical solutions. Its products are designed to improve patient outcomes and quality of life by offering accessible diagnostic and therapeutic options in the healthcare sector. The company’s business model emphasizes integrating cutting-edge science with accessible solutions, positioning itself as a provider of transformative healthcare innovations. By developing non-invasive diagnostic tools for early cancer detection, specialized ophthalmologic treatments, and next-generation cell therapies, YD Bio serves medical professionals and patients globally. Its focus on pioneering solutions aligns with the growing demand for early diagnosis and advanced treatment options in the healthcare industry. YD Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about YD Bio stock

Intangible Assets of YD Bio is 2.68 M USD in 2024.

On Eulerpool you can find the complete historical development of Intangible Assets YD Bio since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's YD Bio historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — YD Bio

All Key Metrics — YD Bio